Edward Hurwitz
Director of Finance/CFO bei TURMERIC ACQUISITION CORP.
Vermögen: - $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Edward Hurwitz
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.
466
| College/University | Other Consumer Services | 466 |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts.
49
| Private Company | Investment Managers | 49 |
| Subsidiary | Pharmaceuticals: Generic | 42 | |
| Public Company | Pharmaceuticals: Major | 41 | |
| Subsidiary | Medical Specialties | 26 | |
| Public Company | Biotechnology | 23 | |
Haas School of Business
13
| College/University | Other Consumer Services | 13 |
| Extinct | Pharmaceuticals: Major | 11 | |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX.
10
| Holding Company | Pharmaceuticals: Major | 10 |
| Public Company | Biotechnology | 8 | |
| Private Company | Financial Conglomerates | 7 | |
Protego Biopharma, Inc.
 Protego Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Protego Biopharma operates as a biotechnology firm. The company is headquartered in San Diego, CA.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
Viewpoint Therapeutics, Inc.
 Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Viewpoint Therapeutics, Inc. operates as a biotechnology company. It prevents and treats cataracts and presbyopia, and protein misfolding. The company was founded by Leah Makley in July of 2014 and is headquartered in San Francisco, CA.
4
| Subsidiary | Biotechnology | 4 |
Biointervene, Inc.
 Biointervene, Inc. Pharmaceuticals: MajorHealth Technology Biointervene, Inc. operates as a biopharmaceutical company. The company was founded by Gary J. Bennett and Daniela Salvemini in 2014 and is headquartered in San Diego, CA.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Alta BioPharma Management III LLC
2
| Subsidiary | 2 | |
Rekindle Therapeutics, Inc.
 Rekindle Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rekindle Therapeutics, Inc. operates as an biotechnology company. The company is headquartered in Cambridge, MA.
2
| Private Company | Miscellaneous Commercial Services | 2 |
Alta Partners LP
 Alta Partners LP Investment ManagersFinance Alta Partners LP is a venture capital private equity firm. The private company is based in San Francisco, CA.
1
| Private Company | Investment Managers | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Edward Hurwitz
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| CELGENE | Biotechnology | Corporate Officer/Principal President Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Chief Operating Officer Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Medical Specialties | Chief Executive Officer Director/Board Member Director/Board Member | |
| University of Notre Dame | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| CHIASMA, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
GE Ventures LLC
 GE Ventures LLC Investment ManagersFinance GE Ventures LLC (GE Ventures) is a venture capital subsidiary of General Electric Co. founded in 2000 by James Kim. The firm is headquartered in Menlo Park, California. | Investment Managers | Chief Executive Officer Chief Executive Officer | |
| RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chief Executive Officer Founder | |
| COGENT BIOSCIENCES, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| WAVE LIFE SCIENCES LTD. | Biotechnology | Chairman Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
| Stanford University | College/University | Doctorate Degree Masters Business Admin Masters Business Admin Doctorate Degree | |
| Vanderbilt University | College/University | Doctorate Degree Corporate Officer/Principal | |
| PACIRA BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| BLUEBIRD BIO, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Operating Officer Consultant / Advisor | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Chief Executive Officer Consultant / Advisor Consultant / Advisor Private Equity Analyst | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Masters Business Admin Undergraduate Degree Director/Board Member Doctorate Degree | |
| University of California San Diego | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| University of Florida | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| Georgetown University | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Mitobridge, Inc.
 Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Founder | |
| OSS Healthcare, Inc. | Director/Board Member Director/Board Member | ||
NightstaRx Ltd.
 NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
Atlas Venture Life Science Advisors LLC
 Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor | |
Blade Therapeutics, Inc.
 Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Founder Chairman Chief Tech/Sci/R&D Officer | |
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Biotechnology | Founder Chief Executive Officer Director/Board Member | |
| KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director of Finance/CFO Investor Relations Contact Comptroller/Controller/Auditor | |
| HARPOON THERAPEUTICS, INC. | Biotechnology | Founder Director/Board Member Director/Board Member | |
| ONCORUS, INC. | Biotechnology | Chairman Chief Executive Officer Director/Board Member | |
Bioimpact Capital LLC
 Bioimpact Capital LLC Investment ManagersFinance MPM BioImpact LLC (MPM BioImpact) is a venture capital firm a subsidiary of MPM Bioimpact Inc founded in 1996. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor Director of Finance/CFO Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor | |
Nextpoint Therapeutics, Inc.
 Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nextpoint Therapeutics, Inc. is a biotech company based in Cambridge, MA. The company is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. The company's innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Nextpoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies. Detlev Biniszkiewicz has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Chairman Director/Board Member Chairman Director/Board Member | |
Orna Therapeutics, Inc.
 Orna Therapeutics, Inc. BiotechnologyHealth Technology Orna Therapeutics, Inc. is a biotechnology company that designs and delivers fully engineered circular RNA therapeutics to treat diseases. Orna Therapeutics is based in Cambridge, MA, and has subsidiaries in the United States. The company's proprietary platform combines novel technology to create RNA that drives protein expression with validated and unique delivery solutions. Orna has many advantages over traditional approaches, including simplified production, improved formulatability, and superior protein expression. The company was founded by Daniel Anderson, Raffaella Squilloni, Alex Wesselhoeft, and the CEO is Thomas M. Barnes. | Biotechnology | Chairman Chief Executive Officer Director/Board Member | |
| CULLINAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member | |
| GENERATION BIO CO. | Pharmaceuticals: Major | Founder Director/Board Member Founder | |
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
| ITEOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Aktis Oncology, Inc.
 Aktis Oncology, Inc. Medical/Nursing ServicesHealth Services Aktis Oncology, Inc. is a biotechnology company located in Boston, MA. The company specializes in the discovery and development of a new class of targeted alpha radiopharmaceuticals to treat a broad range of solid tumor cancers. The company's molecules are designed for high tumor penetration and long residence time, which maximizes tumor elimination while minimizing side effects of treatment. The approach enables clinicians to visualize and verify target engagement prior to exposure to therapeutic radioisotopes. Founded and incubated by MPM Capital, Aktis Oncology has developed proprietary platforms to generate tumor targeting agents with ideal properties for alpha radiotherapy. Matt M. Roden has been the CEO of the company since 2020. | Medical/Nursing Services | Chairman Chief Executive Officer Corporate Officer/Principal | |
Renagade Therapeutics, Inc.
 Renagade Therapeutics, Inc. BiotechnologyHealth Technology Renagade Therapeutics, Inc. is an American US-based company that aims to overcome the limitations of RNA medicines by applying their comprehensive deliver, code, edit, insert technologies to precisely correct disease on an unprecedented scale. The company has developed a broad portfolio of RNA delivery systems, which profoundly expand the array of addressable diseases. The company's proprietary, synergistic toolkit allows them to precisely deliver, code, edit, and insert RNA medicines to treat any disease, anywhere in the body. Renagade is built on a foundation of proprietary delivery technologies to unlock previously inaccessible cells, reprogramming cells with superior expression using the leading RNA coding platform via joint venture with Orna Therapeutics, enabling curative therapies by permanently correcting defective genes with proprietary technology, and industry-leading all-RNA system to enable exon or large gene insertions as a gene therapy 2.0 platform. Renagade is backed by MPM BioImpact and F2 Ventures, leading financial groups who have supported the development of over 50 products to market. | Biotechnology | Founder Director/Board Member Founder | |
CODA Biotherapeutics, Inc.
 CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology CODA Biotherapeutics, Inc. engages in the development of chemo genetic neuromodulation platform for the treatment of severe neurological disorders. The company was founded by Mitchell H. Finer, Allan Basbaum, Nicholas Boulis, Joseph Glorioso III and Kenneth P. Greenberg in 2014 and is headquartered in South San Francisco, CA. | Medical Specialties | Director/Board Member Director/Board Member Founder | |
| NIGHTSTAR THERAPEUTICS PLC | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chairman |
Statistik
International
| Vereinigte Staaten | 48 |
| Vereinigtes Königreich | 3 |
| Singapur | 2 |
Sektoral
| Health Technology | 29 |
| Consumer Services | 10 |
| Finance | 6 |
| Commercial Services | 4 |
| Health Services | 3 |
Operativ
| Director/Board Member | 545 |
| Corporate Officer/Principal | 235 |
| Independent Dir/Board Member | 145 |
| Chairman | 87 |
| Undergraduate Degree | 82 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Ansbert Gadicke | 56 |
| Luke Evnin | 42 |
| Susan Siegel | 40 |
| Peter Thompson | 39 |
| Todd Foley | 38 |
| Arnold Lewis Oronsky | 35 |
| Emmett Cunningham | 28 |
| David Stack | 27 |
| Briggs Morrison | 26 |
| Mitchell Finer | 26 |
| Pablo Cagnoni | 24 |
| Jason Rhodes | 24 |
| Eran Nadav | 21 |
| Martin Vogelbaum | 20 |
| Farah Champsi | 19 |
- Börse
- Insiders
- Edward Hurwitz
- Unternehmensverbindungen
